Artificial Sweetener Erythritol Raises the Possibility of Heart Attack.

According to a recent study, the artificial sweetener Erythritol is linked to an increased risk of heart attack and stroke. Let's find out more in detail.

The artificial sweetener called Erythritol often used as an alternative to sugar by the people with diabetes, obesity, and those who want to lose weight. It helps control blood sugar levels and achieves weight loss. It has zero calories. Erythritol is a popular artificial sweetener that is widely available in India and abroad.

Erythritol is artificial sweetener made by fermenting corn and is around 70% as sweet as sugar. Erythritol is poorly metabolised by the body after consumption. The experts have noted that because the human body normally produces very little amounts of erythritol, any additional ingestion can accumulate.

However, a recent study from the Cleveland Clinic that was published in the journal Nature Medicine warns that using artificial sweeteners as a replacement for sugar may carry long-term dangers. The study claims that long term use of this particular artificial sweetener is associated with an increased risk of heart attack and stroke. This study involved 4,000 individuals from the US and Europe, some of whom had a high risk of developing cardiovascular problems.

The Researchers also examined the effects of adding Erythritol to either whole blood or isolated platelets, which are cell fragments that clump together to stop bleeding and contribute to blood clots. The results show that erythritol promoted platelet activation and clot formation. Such clusters block blood flow in different parts of the body.

“Sweeteners like erythritol have rapidly increased in popularity in recent years but there needs to be more in-depth research into their long-term effects,” said senior author Stanley Hazen, MD, Ph D, chairman of the Department of Cardiovascular & Metabolic Sciences in Lerner Research Institute and co-section head of Preventive Cardiology at Cleveland Clinic.

Tags : #editorspick #Erythritol #lowcarb #sugarfree #weightloss #sugarsubstitute #sweetener #smitakumar #medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

In a Miraculous Recovery a 13-Year-Old Girl in Delhi Awakens from Coma After Liver Transplant.May 21, 2024
Tackling Hypertension in South-East Asia: A Call to Action on World Hypertension DayMay 20, 2024
FSSAI's Crackdown on Harmful Fruit Ripening Practices: Ensuring Public Health and ComplianceMay 20, 2024
Uncovering the Presence of Microplastics in Human Blood and Their Health EffectsMay 18, 2024
Potential Risks of Meftal: What Consumers and Doctors Should KnowMay 18, 2024
Over-the-Counter Medications in India: A New Era of AccessibilityMay 18, 2024
DCGI Acts Against Overcharging: New Regulations for Blood CentresMay 17, 2024
Cattle as Hosts for Human and Bird Flu Viruses: A Potential Public Health ConcernMay 17, 2024
The Ethics of Live Surgery Broadcasts: NMC Seeks Public OpinionMay 17, 2024
Successful Removal of 3.7 KG Large Abdominal Tumor from 14-Year-Old Somalian Girl at KIMS Cuddles HospitalMay 16, 2024
iLEAD Sets a Precedent by Launching a Graphic Anthology Authored by Multimedia, Animation and Graphics Students May 16, 2024
Ramaiah Memorial Hospital Launches Novel Intra-Operative Radiation Therapy (IORT); Achieves significant advancement in Cancer Treatment to Enhance Quality of LifeMay 16, 2024
IIITH Announces Product Management Summer SchoolMay 16, 2024
Çelebi India's Delhi Cargo Terminal Successfully Handles Airbus H125 Helicopter ShipmentMay 16, 2024
Plant-Based Diets and Prostate Cancer: New UCSF Study Shows Promising ResultsMay 16, 2024
National Medical Commission Approves 112 New Medical CollegesMay 16, 2024
Study Suggests That Chemotherapy Results in Physical Decline for Older Women with Breast CancerMay 16, 2024
Google DeepMind's AlphaFold 3: Revolutionizing Drug Discovery with AIMay 16, 2024
Hester Biosciences Ltd reports Consolidated Revenue growth of 18% at Rs. 79.3 crore, EBITDA up 37% to Rs. 16.4 crore and Net Profit up 12% to Rs. 6.40 crore in Q4FY24May 16, 2024
Akshay Tritiya Parna Mahotsav heldMay 16, 2024